Antiva Biosciences Funding & Investors
South San Francisco, CA
Antiva Biosciences, Inc. is a clinical stage biopharmaceutical company developing novel, topical therapeutics for the treatment of diseases caused by HPV infection. They aim to stop cancer before it starts by treating the pre-cancerous lesions caused by HPV.
antivabio.comTotal Amount Raised: $140,971,024
Antiva Biosciences' Investors
Antiva Biosciences Funding Rounds
Series E
$53,000,000
Series E Investors
MPM BioImpactAdjuvant CapitalSofinnova VenturesCanaan PartnersGVLumira VenturesHBM PartnersSeries D
$31,000,000
Series D Investors
Adjuvant CapitalDong-A ST Co.Brace Pharma CapitalOsage University Partners IISirona CapitalGaingelsLumira VenturesGVMana VenturesCanaan PartnersSofinnova VenturesAlexandria Venture InvestmentsHBM Healthcare InvestmentsAvestria VenturesSeries C
$15,000,000
Series C Investors
Hillhouse CapitalSirona CapitalOsage University Partners IISofinnova VenturesBrace Pharma CapitalCanaan PartnersJLABSNS InvestmentAlexandria Venture InvestmentsSeries C
$22,000,000
Series C Investors
Brace Pharma CapitalNS InvestmentOsage University Partners IIAlexandria Venture InvestmentsCanaan PartnersSofinnova VenturesSeries B
$16,000,000
Series B Investors
Canaan PartnersSofinnova VenturesWende HuttonSeries Unknown
$1,745,019
Debt Financing
$1,100,000
Series Unknown
$1,126,006
Funding info provided by Diffbot.